A Phase 1 Study of Mixed Bacteria Vaccine (MBV) in Patients With Tumors Expressing NY-ESO-1 Antigen
Ludwig Institute for Cancer Research
Ludwig Institute for Cancer Research
Novartis
Dartmouth-Hitchcock Medical Center
INSYS Therapeutics Inc
National Cancer Institute (NCI)
European Organisation for Research and Treatment of Cancer - EORTC
European Organisation for Research and Treatment of Cancer - EORTC
Northwestern University
Astellas Pharma Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
NYU Langone Health